Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLESS: Beta-lactam Plus Levofloxacin for Streptococcal Bacteremia
NCT07240077Phase 4Recruiting
- Sponsor
- Mahidol University
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levofloxacin in Streptococcal bacteremia, sponsored by Mahidol University. Started Jan 2026; status: recruiting.
02
Drugs
levofloxacin
03
Conditions
Streptococcal bacteremia
Beyond the preview
Go deeper on NCT07240077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07240077.